300 related articles for article (PubMed ID: 22743037)
41. HAART-persistent HIV-1 latent reservoirs: their origin, mechanisms of stability and potential strategies for eradication.
Kulkosky J; Bray S
Curr HIV Res; 2006 Apr; 4(2):199-208. PubMed ID: 16611058
[TBL] [Abstract][Full Text] [Related]
42. Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART.
Aiuti F; Mezzaroma I
AIDS Rev; 2006; 8(2):88-97. PubMed ID: 16848276
[TBL] [Abstract][Full Text] [Related]
43. Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat.
Olesen R; Vigano S; Rasmussen TA; Søgaard OS; Ouyang Z; Buzon M; Bashirova A; Carrington M; Palmer S; Brinkmann CR; Yu XG; Østergaard L; Tolstrup M; Lichterfeld M
J Virol; 2015 Oct; 89(20):10176-89. PubMed ID: 26223643
[TBL] [Abstract][Full Text] [Related]
44. HIV DNA subspecies persist in both activated and resting memory CD4+ T cells during antiretroviral therapy.
Murray JM; Zaunders JJ; McBride KL; Xu Y; Bailey M; Suzuki K; Cooper DA; Emery S; Kelleher AD; Koelsch KK;
J Virol; 2014 Mar; 88(6):3516-26. PubMed ID: 24403590
[TBL] [Abstract][Full Text] [Related]
45. Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines.
Chun TW; Engel D; Mizell SB; Ehler LA; Fauci AS
J Exp Med; 1998 Jul; 188(1):83-91. PubMed ID: 9653086
[TBL] [Abstract][Full Text] [Related]
46. Potential role of immune modulation in the effective long-term control of HIV-1 infection.
Rizzardi GP; Lazzarin A; Pantaleo G
J Biol Regul Homeost Agents; 2002; 16(1):83-90. PubMed ID: 12003181
[TBL] [Abstract][Full Text] [Related]
47. Reservoirs of HIV-1 in vivo: implications for antiretroviral therapy.
Saksena NK; Potter SJ
AIDS Rev; 2003; 5(1):3-18. PubMed ID: 12875103
[TBL] [Abstract][Full Text] [Related]
48. In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection.
Tsai P; Wu G; Baker CE; Thayer WO; Spagnuolo RA; Sanchez R; Barrett S; Howell B; Margolis D; Hazuda DJ; Archin NM; Garcia JV
Retrovirology; 2016 May; 13(1):36. PubMed ID: 27206407
[TBL] [Abstract][Full Text] [Related]
49. Finding a cure for HIV: will it ever be achievable?
Lewin SR; Evans VA; Elliott JH; Spire B; Chomont N
J Int AIDS Soc; 2011 Jan; 14():4. PubMed ID: 21255462
[TBL] [Abstract][Full Text] [Related]
50. Activation of Latent HIV-1 T Cell Reservoirs with a Combination of Innate Immune and Epigenetic Regulators.
Palermo E; Acchioni C; Di Carlo D; Zevini A; Muscolini M; Ferrari M; Castiello L; Virtuoso S; Borsetti A; Antonelli G; Turriziani O; Sgarbanti M; Hiscott J
J Virol; 2019 Nov; 93(21):. PubMed ID: 31413127
[TBL] [Abstract][Full Text] [Related]
51. Autologous IgG antibodies block outgrowth of a substantial but variable fraction of viruses in the latent reservoir for HIV-1.
Bertagnolli LN; Varriale J; Sweet S; Brockhurst J; Simonetti FR; White J; Beg S; Lynn K; Mounzer K; Frank I; Tebas P; Bar KJ; Montaner LJ; Siliciano RF; Siliciano JD
Proc Natl Acad Sci U S A; 2020 Dec; 117(50):32066-32077. PubMed ID: 33239444
[TBL] [Abstract][Full Text] [Related]
52. Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation.
Shan L; Deng K; Shroff NS; Durand CM; Rabi SA; Yang HC; Zhang H; Margolick JB; Blankson JN; Siliciano RF
Immunity; 2012 Mar; 36(3):491-501. PubMed ID: 22406268
[TBL] [Abstract][Full Text] [Related]
53. Effector memory differentiation increases detection of replication-competent HIV-l in resting CD4+ T cells from virally suppressed individuals.
Wonderlich ER; Subramanian K; Cox B; Wiegand A; Lackman-Smith C; Bale MJ; Stone M; Hoh R; Kearney MF; Maldarelli F; Deeks SG; Busch MP; Ptak RG; Kulpa DA
PLoS Pathog; 2019 Oct; 15(10):e1008074. PubMed ID: 31609991
[TBL] [Abstract][Full Text] [Related]
54. Redefining the viral reservoirs that prevent HIV-1 eradication.
Eisele E; Siliciano RF
Immunity; 2012 Sep; 37(3):377-88. PubMed ID: 22999944
[TBL] [Abstract][Full Text] [Related]
55. Viral latency and potential eradication of HIV-1.
Matreyek KA; Oztop I; Freed EO; Engelman A
Expert Rev Anti Infect Ther; 2012 Aug; 10(8):855-7. PubMed ID: 23030323
[TBL] [Abstract][Full Text] [Related]
56. The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency.
Mousseau G; Kessing CF; Fromentin R; Trautmann L; Chomont N; Valente ST
mBio; 2015 Jul; 6(4):e00465. PubMed ID: 26152583
[TBL] [Abstract][Full Text] [Related]
57. Maintenance of CD4+ T-cell memory and HIV persistence: keeping memory, keeping HIV.
Chomont N; DaFonseca S; Vandergeeten C; Ancuta P; Sékaly RP
Curr Opin HIV AIDS; 2011 Jan; 6(1):30-6. PubMed ID: 21242891
[TBL] [Abstract][Full Text] [Related]
58. Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy.
Liu B; Zou F; Lu L; Chen C; He D; Zhang X; Tang X; Liu C; Li L; Zhang H
J Virol; 2016 Nov; 90(21):9712-9724. PubMed ID: 27535056
[TBL] [Abstract][Full Text] [Related]
59. Therapeutic Approaches to Eradicate Latent HIV-1 in Resting CD4+ T Cells.
Sluis-Cremer N
Curr Top Med Chem; 2016; 16(10):1191-7. PubMed ID: 26324046
[TBL] [Abstract][Full Text] [Related]
60. In patients on prolonged HAART, a significant pool of HIV infected CD4 T cells are HIV-specific.
Demoustier A; Gubler B; Lambotte O; de Goër MG; Wallon C; Goujard C; Delfraissy JF; Taoufik Y
AIDS; 2002 Sep; 16(13):1749-54. PubMed ID: 12218385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
